|
|
Volumn 81, Issue 1, 2002, Pages 40-45
|
|
Current therapeutical management, new antibiotics and treatment of pseudomonas aeruginosa in bacterial ENT-infections;Anmerkungen zu aktuellen therapiestrategien, neuen antibiotika und pseudomonas aeruginosa bei bakteriellen HNO-infektionen
a
|
|
Author keywords
Antibiotic treatment; Dose reduction; ENT infections; P. aeruginosa; Pharmacoeconomical benefits; Sequential therapy; Short course therapy
|
|
Indexed keywords
AMINOPENICILLIN;
ANTIBIOTIC AGENT;
CARBAPENEM;
CEFACLOR;
CEFADROXIL;
CEFALEXIN;
CEFIXIME;
CEFPODOXIME PROXETIL;
CEFSULODIN;
CEFTAZIDIME;
CEFTIBUTEN;
CEFUROXIME AXETIL;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
CLINDAMYCIN;
GENTAMICIN;
IMIPENEM;
KETOLIDE;
MACROLIDE;
PENICILLIN V;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CHRONIC OTITIS MEDIA;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DISEASE DURATION;
DRUG EFFICACY;
EAR NOSE THROAT DISEASE;
EXTERNAL OTITIS;
GRAM NEGATIVE INFECTION;
HAEMOPHILUS INFLUENZAE;
HUMAN;
MORAXELLA CATARRHALIS;
OTITIS MEDIA;
PARANASAL SINUSITIS;
PERICHONDRITIS;
PHARYNGITIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
STREPTOCOCCUS PYOGENES;
TONSILLITIS;
TREATMENT OUTCOME;
CEFTAZIDIME;
CHRONIC DISEASE;
CIPROFLOXACIN;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
OTITIS EXTERNA;
OTITIS MEDIA;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
SINUSITIS;
|
|
EID: 0036163558
PISSN: 09358943
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2002-20118 Document Type: Article |
|
Times cited : (5)
|
|
References (11)
|
